Skip to Content


Spaulding Clinical Offers an Expert Response to the Burning Question: Is Your Sunscreen Safe?

May 14, 2019


May 14, 2019 – Spaulding Clinical Research, the contract research organization tapped by the U.S. Food and Drug Administration to conduct a study on the absorption of active ingredients in sunscreen into the bloodstream, announced today that it is now available to design and execute Maximum Usage Trials (MUsTs) for sunscreen and sunscreen-containing products.
For more information on the sunscreen trials, to download the JAMA article or explore conducting a MUsT on your product visit

Back to News

Ready to partner with Spaulding Clinical for your Phase I study?

Let’s Talk